Related Experiment Video
Updated: Oct 12, 2025
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities
Kris Vijay1, Brendon L Neuen2, Edgar V Lerma3,4
1Abrazo Arizona Heart Institute and Hospital, Phoenix, Arizona, USA.
Insights
Heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD) frequently coexist, increasing hospitalization and mortality risks. This review examines their links and treatment strategies for patients with all three conditions.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD) are prevalent and interconnected conditions.
- DM and CKD significantly increase the risk of developing HF, with DM being a leading cause of kidney failure.
- The triple comorbidity of HF, DM, and CKD is associated with substantially elevated risks of hospitalization and mortality.
Purpose of the Study:
- To review the epidemiology and interconnections between HF, DM, and CKD.
- To summarize current clinical evidence for treating patients with these combined comorbidities.
- To discuss potential treatment approaches using a case study.
Main Methods:
- Literature review of epidemiological data and clinical evidence.
- Analysis of shared risk factors and underlying pathophysiological mechanisms.
- Case study presentation to illustrate treatment considerations.
Main Results:
- High prevalence of DM and CKD in HF patients, and vice versa.
- Complex interplay of shared risk factors, inflammation, oxidative stress, and neurohormonal pathways.
- Significant increase in adverse outcomes with the combination of HF, DM, and CKD.
Conclusions:
- Treatment plans for patients with HF, DM, and CKD must integrate available clinical evidence.
- Understanding the complex relationships is crucial for effective management.
- Individualized treatment strategies are necessary for this high-risk population.
Background:
Heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD) are commonly occurring and interlinked conditions. Approximately 25%-40% of patients with HF have DM, and approximately 40%-50% of patients with HF have CKD. Both DM and CKD are associated with increased risk of incident HF. Furthermore, 40% of people with DM develop CKD, making DM the leading cause of kidney failure globally. Importantly, 16% of patients with HF have both comorbid DM and CKD, and the combination of these 3 comorbidities is associated with substantially increased risk for hospitalization and mortality. Mechanisms that underlie the relationships between HF, DM, and CKD are complex but likely relate to shared cardiovascular and metabolic risk factors, as well as downstream effects on inflammation, oxidative stress, and neurohormonal pathways.
Summary:
This review outlines the epidemiology and links between HF, DM, and CKD, as well as current clinical evidence for the treatment of individuals with a combination of these comorbidities. A case study of a patient with concomitant HF, DM, and CKD is discussed to explore potential treatment approaches for patients in whom all 3 comorbidities exist.
Key Messages:
Treatment plans for patients with a combination of these 3 comorbidities should consider the available clinical evidence.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
01:18Chronic Kidney Disease IV: Nursing Management
01:25Chronic Kidney Disease I: Introduction
01:22Heart Failure VI: Adjunct Therapies
01:30Heart Failure V: Medical Management
01:28Chronic Kidney Disease III: Interprofessional Care